From: Evaluation of integrin αvβ3-targeted imaging for predicting disease progression in patients with high-risk differentiated thyroid cancer (using 99mTc-3PRGD2)
Disease status
Surgery (n = 10)
RAI (n = 2)
Targeted therapy (n = 2)
Complete cure
4
0
Clinical improvement
2
1
Stable disease
Progressive disease
3
Unknown